Virus-induced Systemic Vasculitides: New Therapeutic Approaches
The best therapeutic strategy in virus-induced vasculitides should take into account the etiology of the disease and be adapted to the pathogenesis. The combination of antiviral treatments and plasma exchanges has been proven effective in polyarteritis nodosa (PAN...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2004-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1080/17402520400001744 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558713657884672 |
|---|---|
| author | Loïc Guillevin |
| author_facet | Loïc Guillevin |
| author_sort | Loïc Guillevin |
| collection | DOAJ |
| description | The best therapeutic strategy in virus-induced vasculitides should take
into account the etiology of the disease and be adapted to the pathogenesis. The
combination of antiviral treatments and plasma exchanges has been proven
effective in polyarteritis nodosa (PAN). In human immunodeficiency virus
(HIV)-related vasculitis this strategy is also effective and does not jeopardize, like
cytotoxic agents, the outcome of AIDS. In vasculitis related to HCV-associated
cryoglobulinemia, plasma exchanges improve the outcome but the poor
effectiveness of antiviral drugs is not able to favor,
usually, a definite recovery of the patients and relapses are frequent. |
| format | Article |
| id | doaj-art-3a47bef816b0420e854e7a97d1c213f3 |
| institution | Kabale University |
| issn | 1740-2522 1740-2530 |
| language | English |
| publishDate | 2004-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical and Developmental Immunology |
| spelling | doaj-art-3a47bef816b0420e854e7a97d1c213f32025-02-03T01:31:39ZengWileyClinical and Developmental Immunology1740-25221740-25302004-01-0111222723110.1080/17402520400001744Virus-induced Systemic Vasculitides: New Therapeutic ApproachesLoïc Guillevin0Department of Internal Medicine, Hôpital Cochin, AP-HP, Université René Descartes-Paris V, Paris, FranceThe best therapeutic strategy in virus-induced vasculitides should take into account the etiology of the disease and be adapted to the pathogenesis. The combination of antiviral treatments and plasma exchanges has been proven effective in polyarteritis nodosa (PAN). In human immunodeficiency virus (HIV)-related vasculitis this strategy is also effective and does not jeopardize, like cytotoxic agents, the outcome of AIDS. In vasculitis related to HCV-associated cryoglobulinemia, plasma exchanges improve the outcome but the poor effectiveness of antiviral drugs is not able to favor, usually, a definite recovery of the patients and relapses are frequent.http://dx.doi.org/10.1080/17402520400001744 |
| spellingShingle | Loïc Guillevin Virus-induced Systemic Vasculitides: New Therapeutic Approaches Clinical and Developmental Immunology |
| title | Virus-induced Systemic Vasculitides: New Therapeutic Approaches |
| title_full | Virus-induced Systemic Vasculitides: New Therapeutic Approaches |
| title_fullStr | Virus-induced Systemic Vasculitides: New Therapeutic Approaches |
| title_full_unstemmed | Virus-induced Systemic Vasculitides: New Therapeutic Approaches |
| title_short | Virus-induced Systemic Vasculitides: New Therapeutic Approaches |
| title_sort | virus induced systemic vasculitides new therapeutic approaches |
| url | http://dx.doi.org/10.1080/17402520400001744 |
| work_keys_str_mv | AT loicguillevin virusinducedsystemicvasculitidesnewtherapeuticapproaches |